The plasma levels of IFN-γ and CXCL9 are correlated with HLH flares, whereas serum IL-18 levels are constitutively elevated and persist after initiating IL-1-targeting therapy (53, 54). The gene discussed is IL18; the disease is hemophagocytic syndrome.